10 completed, 3 terminated, 1 active not recruiting, 1 enrolling by invitation. 6 Not applicable, 3 Phase 4, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 6 | Completed 4, Active not recruiting 1, Terminated 1 |
| Phase 4 | 3 | Completed 2, Unknown 1 |
| Phase 2 | 1 | Terminated 1 |
Follow Overactive Detrusor: new trials by email Literature Review of Overactive Detrusor trials Research Report on Overactive Detrusor
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Yoga for Treatment of Overactive Bladder in Pediatric Patients Yoga - Overactive Bladder, Overactive Bladder Syndrome | Not applicable | Terminated | Duke University | 1 | 2025-10-12 | 2026-08-20 |
| Migraine Medication Effects on Urinary Symptoms Ubrogepant, Rimegepant, Atogepant - Overactive Bladder, Bladder Pain Syndrome | Enrolling by invitation | The Cleveland Clinic | 200 | 2024-04-05 | 2026-10-19 | |
| Transcutaneous Tibial Nerve Stimulation for Idiopathic Overactive Bladder Bladder training, Transcutaneous tibial nerve stimulation - Overactive Bladder, Overactive Bladder Syndrome | Not applicable | Active not recruiting | Ege University | 26 | 2023-09-30 | 2026-04-09 |
| Minimizing Pain During Office Intradetrussor Botox Injection Bicarbonate protocol, Standard protocol - Overactive Bladder, Overactive Detrusor | Phase 4 | Completed | Boston Urogynecology Associates | 85 | 2020-08-15 | 2025-03-06 |
| Comparison of Different Treatments for Overactive Bladder Syndrome Pelvic Floor Exercise Group, Kinesio tape, Electrical stimulation - Overactive Bladder, Overactive Bladder Syndrome | Not applicable | Completed | Ankara Yildirim Beyazıt University | 66 | 2019-12-06 | 2021-01-26 |
| Efficacy of Two Onabotulinum Toxin Doses Injection of Onabotulinum toxin - Neurogenic Bladder, Overactive Detrusor | Completed | Swiss Paraplegic Research, Nottwil | 56 | 2018-02-01 | 2019-08-06 | |
| Reproductibility of Cystometry in Multiple Sclerosis Patient Lower Urinary Tract Symptoms, Cystometry | Completed | Pierre and Marie Curie University | 31 | 2017-07-02 | 2018-03-01 | |
| Sensitivity of Extended Cultures in Diagnosing Urinary Tract Infections Extended Urine Culture - Overactive Bladder, Overactive Detrusor | Terminated | The Cleveland Clinic | 16 | 2017-07-01 | 2018-09-04 | |
| Effects of Transcutaneous and Percutaneous PTNS on Idiopathic OAB PTNS, TENS SNS - Overactive Bladder, Urge Incontinence | Not applicable | Completed | Instituto Médico Tecnológico SL | 68 | 2015-11-01 | 2017-08-21 |
| Botulinum Toxin in the Treatment of Idiopathic Detrusor Overactivity Botulinum toxin injected to bladder body, Botulinum toxin injected into trigone - Overactive Detrusor | Phase 4 | Unknown | Mr HD Flood | 60 | 2013-12-01 | 2013-12-12 |
| Prognostic Value of the Urinary Nerve Growth Factor in the Patients With Benign Prostatic Hyperplasia Holmium Laser Enucleation of the Prostate (HoLEP), Holmium laser enucleation system and morcellator - Benign Prostatic Hypertrophy With Outflow Obstruction, Overactive Detrusor | Not applicable | Completed | KYU-SUNG LEE | 184 | 2013-02-01 | 2019-12-02 |
| Plantarflexion Reduces Urgency and Peak Detrusor Pressure in Patients With Detrusor Overactivity Plantarflexion 2nd wave, Plantarflexion - 3rd wave - Overactive Detrusor | Not applicable | Completed | Assaf-Harofeh Medical Center | 22 | 2012-06-01 | 2019-03-11 |
| Safety and Efficacy Evaluation of Oxybutynin Topical Gel In Children With Neurogenic Bladder Oxybutynin, Placebo - Overactive Detrusor, Neurogenic Bladder | Phase 4 | Completed | AbbVie | 52 | 2011-05-17 | 2024-09-04 |
| "Swallow my Urine Back" : Inhibition of Detrusor Overactivity by Swallowing Maneuver Overactive Detrusor | Completed | Assaf-Harofeh Medical Center | 20 | 2011-04-01 | 2011-08-09 | |
| Onabotulinumtoxina Intradetrusorial Injections and NGF Expression Overactive Detrusor, Detrusor Hyperreflexia of Bladder | Completed | University Of Perugia | 25 | 2009-01-01 | 2012-06-27 | |
| Study of Darifenacin in Patients Suffering From Multiple Sclerosis and Neurogenic Detrusor Overactivity Darifenacin (BAY79-4998) - Multiple Sclerosis, Overactive Detrusor | Phase 2 | Terminated | Bayer | 7 | 2007-02-01 | 2014-12-02 |
Urinary Bladder, Overactive (16) · Multiple Sclerosis (2) · Urinary Bladder, Neurogenic (2) · Urinary Incontinence, Urge (2) · Cystitis, Interstitial (1) · Lower Urinary Tract Symptoms (1) · Migraine Disorders (1) · Spasm (1) · Urinary Tract Infections (1)
Female Urogenital Diseases (16) · Female Urogenital Diseases and Pregnancy Complications (16) · Male Urogenital Diseases (16) · Pathological Conditions, Signs and Symptoms (16) · Signs and Symptoms (16) · Urinary Bladder Diseases (16) · Urogenital Diseases (16) · Urologic Diseases (16) · Urological Manifestations (16) · Lower Urinary Tract Symptoms (15) · Nervous System Diseases (6) · Neurologic Manifestations (3) · Autoimmune Diseases (2) · Autoimmune Diseases of the Nervous System (2) · Demyelinating Autoimmune Diseases, CNS (2)
Botulinum Toxins, Type A (2) · AIEOP acute lymphoblastic leukemia protocol (1) · Athletic Tape (1) · Botulinum Toxins (1) · Electric Stimulation (1) · Yoga (1) · atogepant (1) · darifenacin (1) · eptinezumab (1) · erenumab (1) · fremanezumab (1) · galcanezumab (1) · oxybutynin (1) · rimegepant sulfate (1) · ubrogepant (1)
Assaf-Harofeh Medical Center (2) · The Cleveland Clinic (2) · AbbVie (1) · Ankara Yildirim Beyazıt University (1) · Bayer (1) · Boston Urogynecology Associates (1) · Duke University (1) · Ege University (1) · Instituto Médico Tecnológico SL (1) · KYU-SUNG LEE (1) · Mr HD Flood (1) · Pierre and Marie Curie University (1) · Swiss Paraplegic Research, Nottwil (1) · University Of Perugia (1)
United States (5) · Turkey (Türkiye) (2) · France (1) · Germany (1) · Ireland (1) · Israel (1) · Italy (1) · South Korea (1) · Spain (1) · Switzerland (1)
Kobi Stav, MD (2) · Ece Cinar, MD (1) · Eric Hurtado, MD (1) · H D Flood, FRCSI (1) · Howard B Goldman, MD (1) · Kyu-Sung Lee, M.D., Ph.D. (1)